InVivo Therapeutics Holdings buy melinda
Start price
31.07.17
/
50%
€32,134
Target price
19.12.17
€40,590
Performance (%)
-53.52%
End price
19.12.17
€14,937
Summary
This prediction ended on 19.12.17 with a price of €14,937. The BUY prediction by melinda for InVivo Therapeutics Holdings performed very badly with a performance of -53.52%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
InVivo Therapeutics Holdings | 1.899% | 1.899% | -69.907% | -99.932% |
iShares Core DAX® | -0.383% | 5.021% | 16.188% | 19.224% |
iShares Nasdaq 100 | 1.248% | 4.007% | 36.579% | 57.508% |
iShares Nikkei 225® | 0.525% | -0.109% | 12.378% | 9.329% |
iShares S&P 500 | 0.640% | 3.649% | 28.752% | 47.932% |
According to melinda what are the pros and cons of InVivo Therapeutics Holdings for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Invivo Therapeutics diskutieren
Biotechnologie
(Vom Mitglied beendet)
Stopped prediction by melinda for InVivo Therapeutics Holdings
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€7.59
01.04.22
01.04.22
€12.50
01.04.23
01.04.23
-76.56%
04.03.23
04.03.23
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€8,963.6
04.02.18
04.02.18
€11,670
08.03.18
08.03.18
67.91%
08.03.18
08.03.18
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€35,625
31.07.17
31.07.17
€45,000
19.12.17
19.12.17
-53.52%
19.12.17
19.12.17
Could be worthwhile Investment >10% per year